Skip to main content
Figure 1 | Italian Journal of Pediatrics

Figure 1

From: Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions

Figure 1

NAFLD pathogenesis-driven old and novel potential treatments in pediatric NAFLD/NASH. Symbols: * current , ** potential, and/or *(*) partially established therapeutic approaches in pediatric NAFLD. ABBREVIATIONS DHA, docosahexanoic acid; DPP-4, dipeptidyl peptidase-4; FFA, free fatty acid; FXR, farnesoid X receptor; NAFLD, non alcoholic fatty liver disease; NASH, non alcoholic steatohepatitis; TLR, toll-like receptor; UDCA, ursodeoxycholic acid.

Back to article page